SLAM
NKTR icon

Swiss Life Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Swiss Life Asset Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,447
Closed -$83.3K – 632
2022
Q4 		$83.3K Buy
2,447
+66
+3% +$3.19K ﹤0.01% 595
2022
Q3 		$114K Buy
2,381
+142
+6% +$8.45K ﹤0.01% 574
2022
Q2 		$128K Hold
2,239
– – ﹤0.01% 612
2022
Q1 		$181K Sell
2,239
-14
-0.6% -$2.07K ﹤0.01% 566
2021
Q4 		$456K Hold
2,253
– – 0.01% 513
2021
Q3 		$606K Hold
2,253
– – 0.01% 494
2021
Q2 		$579K Sell
2,253
-165
-7% -$45.7K 0.01% 497
2021
Q1 		$725K Sell
2,418
-46
-2% -$14.3K 0.01% 458
2020
Q4 		$628K Hold
2,464
– – 0.01% 462
2020
Q3 		$612K Hold
2,464
– – 0.01% 401
2020
Q2 		$857K Hold
2,464
– – 0.01% 381
2020
Q1 		$661K Hold
2,464
– – 0.01% 406
2019
Q4 		$800K Sell
2,464
-726
-23% -$211K 0.02% 405
2019
Q3 		$871K Sell
3,190
-5,632
-64% -$2.07M 0.01% 404
2019
Q2 		$4.7M Buy
8,822
+7,271
+469% +$3.65M 0.06% 191
2019
Q1 		$781K Buy
+1,551
New +$919K 0.01% 386
2018
Q4 		– Sell
-2,316
Closed -$2.12M – 374
2018
Q3 		$2.12M Buy
2,316
+1,733
+297% +$1.48M 0.03% 306
2018
Q2 		$427K Buy
+583
New +$672K 0.01% 452

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Swiss Life Asset Management's NKTR Position: Q1 2023 in Review

Swiss Life Asset Management sold out of Nektar Therapeutics (NKTR) in Q1 2023, closing a stake of 2,447 shares — an estimated $83.3K sold.

Swiss Life Asset Management first reported a position in NKTR in Q2 2018 and held it in 18 quarters. The position peaked at $4.7M in Q2 2019. 194 funds tracked by Wall St. Rank hold NKTR as of Q1 2023.

  • Swiss Life Asset Management reported no remaining Nektar Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Swiss Life Asset Management sold 2,447 Nektar Therapeutics shares in Q1 2023, an estimated $83.3K.
  • Swiss Life Asset Management first reported a position in Nektar Therapeutics in Q2 2018 and held it in 18 quarters.
  • Swiss Life Asset Management's Nektar Therapeutics position peaked at $4.7M in Q2 2019.
  • 194 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2023.

Based on Swiss Life Asset Management's 13F filing for Q1 2023, filed 9 Dec 2025.